CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop an innovative platform for treating chronic migraine using a combination of implantable electronics, a wearable device, a mobile app, and a minimally invasive injection device. The goal is to provide a non-surgical, effective solution that increases accessibility for underserved patients, p…
Chronic migraine is defined as a headache persistent for more than 3 months or a severe headache persistent for more than 15 days within a month.
It affects approximately 2% of the world population.
The World Health Organization classifies severe migraine attacks as among the most disabling illnesses, comparable to dementia and quadriplegia.
Treatments start with pharmaceutical drugs, which have contra-indications and severe side effects and often remain ineffective in chronic migraine patients.…
UNIVERSITA DI PISA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, APRILIA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Ireland, CORK
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Slovenia, Maribor
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Belgium, GENT
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
